News Releases

Mar 02, 2021 Pulmonx Reports Fourth Quarter and Full Year 2020 Financial Results
REDWOOD CITY, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and full year of 2020 ended December 31, 2020.
Feb 16, 2021 Pulmonx to Report Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021
REDWOOD CITY, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the fourth quarter and full year of 2020 after the close of trading
Print Page
Email Alerts
Contact IR
RSS Feeds